ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668258 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668258; 2) Community: the network communities that were significantly associated with the response to NSC 668258; 3) Molecule: the relationships between components within communities and NSC 668258; 4) MDR: the compounds that were significantly associated with the NSC 668258.

NSC Compound Enrichment Correlation
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.00334162892839396 0.64600242
NSC 39215 Null 0.00334162892839396 0.5912071
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.00334162892839397 0.73185575
NSC 693867 Null 0.00334162892839397 0.49951487
NSC 694075 Null 0.00334162892839397 0.55923539
NSC 727086 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-3a-pyrrolidino-5-androsten-17a-yl acetate 0.00334162892839397 0.4314183
NSC 736163 pyrazoline derivative 0.00334162892839397 0.43985537
NSC 331935 CHALCONE ANALOG 0.00337662564965907 0.48645495
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.00337662564965907 0.72618705
NSC 625502 Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, 0.00337662564965907 0.71010029
Total:101  Current:14    [First] [Prev] [Next] [Last]